0000000000674334

AUTHOR

Joachim Cordes

showing 4 related works from this author

Dopamine D2 Receptor Occupancy Estimated From Plasma Concentrations of Four Different Antipsychotics and the Subjective Experience of Physical and Me…

2019

Background Impaired subjective well-being in schizophrenia patients treated with antipsychotics has often been linked inter alia to the antidopaminergic effects of medication. Thus, it is important to capture the association between striatal dopamine D2 receptor occupancy (D2-RO) and global subjective well-being. We examined this association using data from our multicenter, randomized, double-blind Neuroleptic Strategy Study (NeSSy). Methods An innovative double randomization process was used for allocation of patients to the specific treatment groups. Plasma drug concentrations were measured after 6 and 24 weeks of treatment to obtain the estimated D2-RO (eD2-RO) relative to literature val…

AdultMaleOlanzapinemedicine.medical_specialtymedicine.medical_treatmentAripiprazolePersonal SatisfactionMedication Adherencelaw.invention03 medical and health sciencesSex Factors0302 clinical medicineDouble-Blind MethodRandomized controlled triallawInternal medicinemedicineHaloperidolHumansPharmacology (medical)AntipsychoticReceptors Dopamine D2business.industryMiddle Agedmedicine.disease3. Good health030227 psychiatryFlupentixolFlupenthixolDopamine D2 Receptor AntagonistsPsychiatry and Mental healthOlanzapineSchizophreniaQuality of LifeSchizophreniaHaloperidolQuetiapineFemaleSchizophrenic PsychologyAripiprazolebusiness030217 neurology & neurosurgeryAntipsychotic Agentsmedicine.drugJournal of Clinical Psychopharmacology
researchProduct

Repetitive Transcranial Magnetic Stimulation (rTMS) Improves Facial Affect Recognition in Schizophrenia

2014

Abstract Objective Facial affect recognition, a basic building block of social cognition, is often impaired in schizophrenia. Poor facial affect recognition is closely related to poor functional outcome; however, neither social cognitive impairments nor functional outcome are sufficiently improved by antipsychotic drug treatment alone. Adjunctive repetitive transcranial magnetic stimulation (rTMS) has been shown to enhance cognitive functioning in both healthy individuals and in people with neuropsychiatric disorders and to ameliorate clinical symptoms in psychiatric disorders, but its effects on social cognitive impairments in schizophrenia have not yet been studied. Therefore, we evaluate…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentBiophysicsPrefrontal CortexStimulationAudiologylcsh:RC321-571Young AdultCognitionDouble-Blind MethodSocial cognitionRepetitive transcranial magnetic stimulation (rTMS)medicineHumansIn patientCognitive skillPsychiatrylcsh:Neurosciences. Biological psychiatry. NeuropsychiatryFacial affectGeneral NeuroscienceMiddle Agedmedicine.diseaseTranscranial Magnetic StimulationFacial affect recognitionTranscranial magnetic stimulationFacial ExpressionAffectSchizophreniaSchizophreniaChronic schizophreniaFemaleSchizophrenic PsychologyNeurology (clinical)PsychologyCognition DisordersBrain Stimulation
researchProduct

EPA guidance on physical activity as a treatment for severe mental illness: a meta-review of the evidence and Position Statement from the European Ps…

2018

AbstractPhysical activity (PA) may be therapeutic for people with severe mental illness (SMI) who generally have low PA and experience numerous life style-related medical complications. We conducted a meta-review of PA interventions and their impact on health outcomes for people with SMI, including schizophrenia-spectrum disorders, major depressive disorder (MDD) and bipolar disorder. We searched major electronic databases until January 2018 for systematic reviews with/without meta-analysis that investigated PA for any SMI. We rated the quality of studies with the AMSTAR tool, grading the quality of evidence, and identifying gaps, future research needs and clinical practice recommendations.…

Societies Scientificmedicine.medical_specialtyCost effectivenessBipolar disorderPsychological interventionPsychosiMajor depressive disorder03 medical and health sciences0302 clinical medicineQuality of life (healthcare)mental disordersSevere mental illnessmedicineHumansBipolar disorderPsychiatryExerciseSocieties MedicalPsychiatryDepressive Disorder Majorbusiness.industryPhysical activitySedentary behaviourmedicine.diseaseMental illnessMental health030227 psychiatryPhysical TherapistsPsychiatry and Mental healthMental HealthSystematic reviewCardiorespiratory FitnessPsychotic DisordersQuality of LifeSchizophreniaMajor depressive disorderSchizophrenic Psychologybusiness030217 neurology & neurosurgery
researchProduct

High frequency repetitive transcranial magnetic stimulation (rTMS) reduces EEG-hypofrontality in patients with schizophrenia.

2015

The reduced metabolic activity in the prefrontal brain lobes, so-called hypofrontality, is associated with increased electrophysiological delta-band activity. Schizophrenia inpatients (N=35) received sham-controlled 10Hz rTMS over the left dorsolateral prefrontal cortex in a randomised design. After treatment, the resting electroencephalography revealed a significant decrease in the delta-band activity, which originated in the right prefrontal cortex and correlated with improvements in facial affect recognition.

AdultMalemedicine.medical_treatmentPrefrontal CortexHypofrontalityElectroencephalography03 medical and health sciences0302 clinical medicinemedicineHumansIn patientPrefrontal cortexBiological PsychiatryFacial affectmedicine.diagnostic_testBrainElectroencephalographymedicine.diseaseTranscranial Magnetic Stimulation030227 psychiatryTranscranial magnetic stimulationPsychiatry and Mental healthElectrophysiologyDelta RhythmSchizophreniaSchizophreniaFemaleSchizophrenic PsychologyPsychologyNeuroscienceFacial Recognition030217 neurology & neurosurgeryPsychiatry research
researchProduct